Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Star Equity Holdings, Inc. furnished a formal investor presentation deck dated October 14, 2026, detailing its business operations and strategy as of June 30, 2026. The presentation outlines the company's approach to creating shareholder value through organic growth, acquisitions, and share repurchases.
CervoMed Inc. announced that it has updated its corporate presentation containing information about its business, clinical studies, and development plans. The presentation is being made available on the company's website and will be used by management in upcoming meetings and conferences with investors and analysts.
High Roller Technologies, Inc. has updated its corporate investor presentation and filed it as an exhibit to this 8-K. The company intends to use the presentation for upcoming meetings with investors, analysts, and other stakeholders to discuss its business strategy and operations.
KiNRG, Inc. made available a formal investor presentation detailing its HydroThermal Reactor (HTR) technology and its strategy for delivering clean energy to data centers and industrial operations. The presentation was filed under Item 7.01 and is intended for use in meetings with prospective investors and in connection with potential capital-raising activities.
Accenture hosted its 2026 Investor Day, providing a review of FY26 performance and outlining strategic financial ambitions through FY29. The company targets mid-single digit revenue growth in FY27-FY28 and mid-to-high single digit growth in FY29, alongside 10-30 bps of annual operating margin expansion.
Upexi, Inc. filed its Fall 2026 investor presentation as an exhibit to be used in upcoming investor conferences and meetings. The presentation provides a strategic and operational update for investors and interested parties.
Intelligent Bio Solutions Inc. has furnished a formal investor presentation relating to its business and operations. Additionally, the company's Board of Directors adopted amended and restated bylaws to clarify stockholder voting procedures, specifically regarding the treatment of abstentions and broker non-votes.
Castellum, Inc. announced its participation in the 2026 Maxim Group Growth Summit on October 14, 2026. Management will be meeting with institutional investors in one-on-one sessions during the named conference event.
Crexendo, Inc. has published a new investor presentation dated October 13, 2026, to its corporate website. The presentation, which was also filed as an exhibit to the SEC Form 8-K, provides updated information for investors and analysts regarding the company's business and strategic outlook.
Oncotelic Therapeutics presented details on its PDAOAI platform and hepatocellular carcinoma (HCC) research at the Drug Discovery 2026 conference. The presentations highlighted a four-gene mTOR-related signature associated with patient survival and introduced the 'BIO REBOOT' initiative to support new therapeutic research projects.
Mobix Labs, Inc. filed an investor presentation dated October 8, 2026, regarding its national security platform initiative. The presentation was used during an investor update call to provide strategic highlights and operational updates to shareholders.
Hydrofarm Holdings Group, Inc. filed a formal investor presentation deck dated October 7, 2026, to be used in upcoming meetings with analysts and market participants. Separately, the company entered into a settlement agreement to resolve claims related to a prior engagement, agreeing to issue 300,000 shares of newly designated non-voting convertible preferred stock.
CervoMed Inc. has updated its corporate investor presentation, which is being made available on the company's website. The presentation covers the company's business, clinical studies, development plans, and financial position, and will be used by management in upcoming meetings with investors and analysts.
eXoZymes Inc. filed a formal Investor Presentation dated October 6, 2026, to be shared with investment bankers and potential investors. The presentation provides strategic highlights and business updates for the company's current and future stakeholders.
Tenax Therapeutics filed an updated investor presentation detailing strategic changes to its Phase 3 LEVEL-2 clinical trial for TNX-103 in PH-HFpEF. The company is pausing enrollment to amend protocol criteria based on findings from its completed LEVEL trial and has requested a Type C meeting with the FDA to discuss the development path.
Braemar Hotels & Resorts announced a definitive agreement to sell the Four Seasons Resort Scottsdale for $372 million as part of its strategic transition to a self-managed REIT. The company also released a comprehensive investor presentation titled 'A New Chapter for Braemar' and provided a 2027 financial outlook following its separation from Ashford Inc.
Mission Produce is hosting its 2026 Investor Day to unveil a five-year growth strategy targeting mid-single-digit organic sales growth and 300 basis points of margin expansion. The company also introduced a long-term 2035 ambition to double sales and triple Adjusted EBITDA while providing an update on its $100 million stock repurchase program.
Term
5 years
“Mission was built to lead. Over more than 40 years, we built the modern avocado category and created a platform that would be difficult to replicate. Our next chapter is about fully leveraging that platform and compounding the value we deliver to shareholders by growing faster than our markets, expanding margins, converting more earnings into cash and deploying that cash with discipline.”
John Pawlowski, President and Chief Executive Officer
Upexi, Inc. announced that its Chief Strategy Officer, Brian Rudick, will participate in several investor conferences in October 2026, including the Maxim Growth Summit, the Webull Emerging & Innovative Companies Webinar, and the LD Micro 20th Annual Main Event. The company, which focuses on digital asset treasury management and consumer brands, will conduct presentations and one-on-one investor meetings at these events.
reAlpha Tech Corp. has posted a new investor presentation to its website for use in upcoming meetings and conferences with investors and analysts. The presentation is accessible via the company's investor relations portal and provides updated information for interested parties.
Bitmine Immersion Technologies published an investor presentation and video transcript delivered by Executive Chairman Tom Lee at the Token2049 Global Conference in Singapore. The filing includes the formal presentation deck and a press release announcing the event under Item 7.01.
Turn Therapeutics Inc. released an updated corporate investor presentation on October 6, 2026. The presentation provides a strategic overview of the company's pipeline and its PermaFusion technology platform for investors.
MAIA Biotechnology, Inc. has prepared and posted a new corporate investor presentation and a summary highlighting its operations and performance to its website. Management intends to use these materials for upcoming presentations to investors and analysts starting October 6, 2026.
60 Degrees Pharmaceuticals updated its investor presentation and held a webinar to discuss interim data from its clinical study of tafenoquine for severe babesiosis. The presentation covers clinical context, DSMB feedback from the hospital study, and the regulatory path forward for the treatment.
Zscaler is hosting its 2026 Investor Day in New York City to discuss its long-term strategy, AI-driven platform innovation, and its path toward a $10 billion ARR target. In conjunction with the event, the company reaffirmed its financial guidance for the first quarter and full fiscal year 2027.
Iovance Biotherapeutics updated its corporate presentation for use at upcoming healthcare conferences and meetings with analysts and stockholders. The presentation provides a corporate overview and strategic update as of October 2026.
Genie Energy Ltd. filed a formal investor presentation deck as an exhibit to be provided to certain investors and made available on its corporate website. The presentation contains forward-looking statements regarding the company's strategic outlook and operations.
Serve Robotics Inc. updated its corporate investor presentation to include preliminary unaudited management estimates regarding its cost of revenue for the fiscal year ending December 31, 2026. The presentation highlights the company's commercial Level 4 autonomous robot fleets and its diversified revenue streams across delivery, healthcare, and advertising.
Moleculin Biotech, Inc. has filed a formal corporate investor presentation as an exhibit to its 8-K. The presentation, dated October 5, 2026, is being used for corporate updates and has been posted to the company's website. The filing was made under Item 7.01 (Regulation FD Disclosure) to provide current information to investors and analysts.
SS Innovations International Investor Presentation
SS Innovations International, Inc. (SSII) filed an updated October 2026 Company Presentation to be used in communications with shareholders and the investment community. The presentation highlights the company's proprietary surgical robotic system, the SSi Mantra 3, and its vision for affordable surgical robotic solutions.
Quantum Computing Inc. (QUBT) has posted an updated investor presentation to its website and filed it as an exhibit to its 8-K. The presentation highlights the company's room-temperature quantum photonics technology, its $1.3 billion cash position with no debt, and its focus on commercializing quantum products for aerospace, defense, and cybersecurity markets.